Induction of Wilms’ tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine

PURPOSE: Wilms’ tumor protein (WT1) is overexpressed in most leukemias and many solid tumors, and is a promising target for tumor immunotherapy. WT1 peptide-based cancer vaccines have been reported but have limited application due to HLA-restriction of the peptides. We sought to vaccinate using aden...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Osada, Takuya, Woo, Christopher Y., McKinney, Matthew, Yang, Xiao Yi, Lei, Gangjun, LaBreche, Heather G., Hartman, Zachary C, Niedzwiecki, Donna, Chao, Nelson, Amalfitano, Andrea, Morse, Michael A., Lyerly, H. Kim, Clay, Timothy M.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3631522/
https://ncbi.nlm.nih.gov/pubmed/19351755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-2589
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items